CME Group (CME) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Mar, 2026Executive summary
Annual meeting scheduled for May 14, 2026, at company headquarters in Chicago, IL.
Shareholders can vote online, by mail, or in person, with materials available electronically or by request.
Voting deadline is May 13, 2026, at 10:59 PM CT.
Voting matters and shareholder proposals
Election of 14 equity directors is on the ballot, with board recommendations for all nominees.
Ratification of Ernst & Young LLP as independent auditor for 2026 is proposed.
Advisory vote on executive compensation (say-on-pay) is included.
Amendments to the certificate of incorporation proposed to eliminate Class B shareholders' special director election rights.
Additional director elections for Class B-1, B-2, and B-3 shareholders, pending approval of amendments.
Board of directors and corporate governance
Board recommends all director nominees for election, including specific Class B director nominees.
Nominating and Governance Committee supports all Class B director nominees.
Latest events from CME Group
- Shareholders to vote on major governance reforms, executive pay, and director elections.CME
Proxy filing23 Mar 2026 - Proposal to eliminate Class B director election rights, with payments to affected shareholders.CME
Proxy Filing12 Mar 2026 - Shareholders to vote on eliminating Class B director election rights amid record financial performance.CME
Proxy Filing12 Mar 2026 - Global growth, product innovation, and high margins drive record performance and shareholder returns.CME
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Record 2025 growth fueled by innovation, global reach, and strong capital efficiencies.CME
Investor presentation3 Mar 2026 - Record revenue, earnings, and trading volumes in 2025, with strong capital returns.CME
Q4 20254 Feb 2026 - Record financials, all proposals approved, and strong outlook amid competition and litigation.CME
AGM 20253 Feb 2026 - Record Q2 revenue, net income, and trading volumes, with growth in every asset class and strong margins.CME
Q2 20243 Feb 2026 - Strong volumes and global uncertainty drive growth focus in equities and credit, with regulatory vigilance.CME
Piper Sandler Global Exchange and Trading Conference 20241 Feb 2026